JD Health International revenue and financials
$35.34Change from previous close: +0.57%Absolute change: +$0.20
In the fiscal year ended December 2025, JD Health International reported revenue of ¥73.44B (+26.28% year over year). Net income was ¥5.38B, a net margin of 7.3%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +26.28%
- 2025 vs 2024
- Net income growth
- +29.16%
- 2025 vs 2024
- Net margin
- 7.3%
- 2024: 7.2%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 |
|---|---|---|---|
| Total assets | 84,171 | 81,587 | 78,460 |
| Current assets | 58,107 | 56,349 | 58,228 |
| Cash and equivalents | 20,446 | 31,785 | 25,177 |
| Short-term investments | 28,828 | 16,366 | 24,129 |
| Inventory | 7,384 | 6,858 | 7,455 |
| Net property, plant and equipment | 1,498 | 1,230 | 964 |
| Other intangible assets | — | 1,933 | — |
| Long-term investments | 166 | 200 | 225 |
| Current liabilities | 21,640 | 20,741 | 19,910 |
| Accounts payable | 14,450 | 13,210 | 13,595 |
| Total debt | 875 | 636 | 430 |
| Total liabilities | 22,715 | 21,513 | 20,483 |
| Total equity (incl. minority) | 61,456 | 60,073 | 57,977 |
| Retained earnings | -4,534 | -7,971 | -10,628 |
| Minority interest | 0.0 | 1.4 | 4.6 |